Business registries · firm from USPTO records
HUVEPHARMA INC.
- Place
- Suite 230 525 Westpark Dr., Peachtree City, GA
- Entity type
- Corporation
- State of organization
- DE (as the owner states it in trademark filings)
- Patents
- 3 granted 1946-07-01 to 2023-07-04
- Trademarks
- 56, 49 live
- Record
- FUZZY medium confidence: same name (legal endings aside) and state
- Federal lobbying client
- HUVEPHARMA FUZZY medium confidence: same name (legal endings aside) and state
- Source
- USPTO: PVGPATDIS and TRCFECO2 (PVGPATDIS file of 2026-04-10, TRCFECO2 file of 2024-03-27); patent assignee and trademark owner with the same name (legal endings aside) and place
Patents
| Patent | Title | Granted | Source |
|---|---|---|---|
| US 11883421 | Functionalized saccharides as anti-inflammatory agents | 2024-01-30 | PVGPATDIS, file of 2026-04-10 |
| US 11692164 | Antibiotic-free compositions for the prevention or control of coccidiosis | 2023-07-04 | PVGPATDIS, file of 2026-04-10 |
| US 11154604 | Adjuvant compositions and related methods | 2021-10-26 | PVGPATDIS, file of 2026-04-10 |
| US 10781418 | Antibiotic-free compositions for the prevention or control of coccidiosis | 2020-09-22 | PVGPATDIS, file of 2026-04-10 |
Trademarks
| Mark | Serial | Filed | Status | Classes | Source |
|---|---|---|---|---|---|
| CLARITY-Q | 97134506 | 2021-11-19 | Registered | 001 | TRCFECO2, file of 2024-03-27 |
| PRIMELINE | 90675276 | 2021-04-27 | Registered | 005 | TRTYRAP, file of 2026-04-03 |
| TERMI-FLY | 90252045 | 2020-10-13 | Registered | 005 | TRCFECO2, file of 2024-03-27 |
| VACASAN | 90019207 | 2020-06-24 | Registered | 005 | TRCFECO2, file of 2024-03-27 |
| VELOXICOL | 90019203 | 2020-06-24 | Abandoned | 005 | TRCFECO2, file of 2024-03-27 |
| AVERT | 88871025 | 2020-04-14 | Registered | 005 | TRTDXFAP, file of 2026-04-22 |
| I-VAX | 88090542 | 2018-08-23 | Abandoned | 005 | TRCFECO2, file of 2024-03-27 |
| KLEBVAX | 87803462 | 2018-02-20 | Registration cancelled | 005 | TRTYRAP, file of 2026-04-03 |
| RESPIVAX | 87721290 | 2017-12-14 | Registered | 005 | TRTDXFAP, file of 2025-05-07 |
| MYCO-B ONE DOSE | 87100647 | 2016-07-12 | Registered | 005 | TRTDXFAP, file of 2026-10-11 |
| ARCTIC MOOSSAGE | 87094707 | 2016-07-06 | Abandoned | 003 | TRCFECO2, file of 2024-03-27 |
| EXACTVAC DNA | 86818385 | 2015-11-12 | Registration cancelled | 005 | TRTDXFAP, file of 2026-10-14 |
| ESSENTIAL CT | 86797979 | 2015-10-23 | Registration cancelled | 003 | TRTYRAP, file of 2026-04-03 |
| ESSENTIAL C3 | 86782216 | 2015-10-08 | Registration cancelled | 003 | TRTYRAP, file of 2026-04-03 |
| CAPRICOAT | 86658357 | 2015-06-10 | Registration cancelled | 003 | TRCFECO2, file of 2024-03-27 |
| BOVICARE | 86493555 | 2014-12-31 | Registered and renewed | 005 | TRTYRAP, file of 2026-04-03 |
| HERBADIP | 86388041 | 2014-09-08 | Registration cancelled | 003 | TRCFECO2, file of 2024-03-27 |
| CARVANELLA | 86377215 | 2014-08-26 | Registration cancelled | 003 | TRCFECO2, file of 2024-03-27 |
| VAXLIANT | 85896283 | 2013-04-05 | Registration cancelled | 005 | TRTYRAP, file of 2026-04-03 |
| ENABL | 85892981 | 2013-04-02 | Registered and renewed | 005 | TRCFECO2, file of 2024-03-27 |
| DI-METHOX | 85339911 | 2011-06-07 | Registered and renewed | 005 | TRCFECO2, file of 2024-03-27 |
| (design) | 85130098 | 2010-09-15 | Registered and renewed | 003 | TRCFECO2, file of 2024-03-27 |
| ACHIEVE | 85105233 | 2010-08-11 | Registered and renewed | 005 | TRCFECO2, file of 2024-03-27 |
| RESPOND | 77945143 | 2010-02-25 | Registered and renewed | 005 | TRCFECO2, file of 2024-03-27 |
| RESPOND | 77945061 | 2010-02-25 | Registered and renewed | 005 | TRCFECO2, file of 2024-03-27 |
The newest 25 of 56. All marks of this owner
Possible related entities
No other firm on file at the same street address.
Firms here are built from USPTO patent assignees (PatentsView) and trademark owners: one firm per name (legal endings aside) and state, or country outside the US. Matches to other records are by name and state: EXACT means the identical full name, FUZZY a looser match, with the confidence shown.